Sue Haupt
- Cancer Research top 2%
- Oncology top 2%
- Cancer-related Molecular Pathways 29
- Molecular Biology top 5%
- Ubiquitin and proteasome pathways 15
- Epigenetics and DNA Methylation 14
- Retinoids in leukemia and cellular processes 11
- RNA modifications and cancer 6
-
- Prostate Cancer Treatment and Research 5
- Biotechnology top 5%
- Cancer Research and Treatments 7
-
- Immunotherapy and Immune Responses 4
- Co-authors
- Ygal HauptElgene LimFranco CaramiaAndrew BurgessCristina GamellValentina ZuckermanKamil WolyniecYaara Levav-Cohen
- Partner nations
- AustraliaUnited StatesIsrael
In The Last Decade
Sue Haupt
66 papers receiving 3.1k citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Cancer Research 695
- Oncology 1.2k
- Molecular Biology 1.9k
- Pulmonary and Respiratory Medicine 626
- Biotechnology 147
Countries citing papers authored by Sue Haupt
This map shows the geographic impact of Sue Haupt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sue Haupt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sue Haupt more than expected).
Fields of papers citing papers by Sue Haupt
This network shows the impact of papers produced by Sue Haupt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sue Haupt. The network helps show where Sue Haupt may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sue Haupt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 14 | |
| 2 | 2023 | 5 | |
| 3 | 2022 | 3 | |
| 4 | 2021 | 28 | |
| 5 | 2021 | 10 | |
| 6 | 2020 | 51 | |
| 7 | 2020 | 9 | |
| 8 | 2019 | 64 | |
| 9 | 2017 | 260 | |
| 10 | 2015 | 10 | |
| 11 | 2015 | 96 | |
| 12 | 2015 | 66 | |
| 13 | 2014 | 31 | |
| 14 | 2013 | 26 | |
| 15 | 2011 | 9 | |
| 16 | 2009 | 52 | |
| 17 | 2009 | 161 | |
| 18 | 2006 | 5 | |
| 19 | 2006 | 39 | |
| 20 | 2005 | 48 |
About Sue Haupt
Sue Haupt is a scholar working on Oncology, Biotechnology and Hematology, having authored 67 papers that have together received 3.1k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (29 papers), Ubiquitin and proteasome pathways (15 papers), Epigenetics and DNA Methylation (14 papers), Retinoids in leukemia and cellular processes (11 papers), Cancer Research and Treatments (7 papers), RNA modifications and cancer (6 papers), Prostate Cancer Treatment and Research (5 papers) and Immunotherapy and Immune Responses (4 papers). The work is most often cited by research in Cancer Research (695 citations), Oncology (1.2k citations) and Molecular Biology (1.9k citations). Sue Haupt has collaborated with scholars based in Australia, United States and Israel. Frequent co-authors include Ygal Haupt, Elgene Lim, Franco Caramia, Andrew Burgess, Cristina Gamell, Valentina Zuckerman, Kamil Wolyniec, Yaara Levav-Cohen, Kee Ming Chia and David M. Thomas. Their work appears in journals such as Frontiers in Oncology, Oncogene, Nature Communications, Anti-Cancer Drugs and The Journal of Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.